Sonnet Biotherapeutics (SONN) Q4 2023 Earnings

14FebConfirmed
Q1 2023
Q2 2023
Q3 2023
Q4 2023
-0.9
-0.64
-0.39
-0.13

Details

Expected EPS
-0.9
Actual EPS
-0.31
Surprise EPS
0.59
Surprise Percent
+65.56%

Description

Sonnet Biotherapeutics (SONN) has reported earnings of -0.31 per share for Q4 2023.

0 Comments

Share your thoughts